Conversion for failed adjustable gastric banding warrants hiatal scrutiny for hiatal hernia.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
07 2019
Historique:
received: 29 06 2018
accepted: 11 10 2018
pubmed: 21 10 2018
medline: 23 4 2020
entrez: 21 10 2018
Statut: ppublish

Résumé

Failure or complications following laparoscopic adjustable gastric banding (LAGB) may necessitate band removal and conversional surgery. Band position and band-induced chronic vomiting create ideal conditions for de novo hiatal hernia (HH) formation. HH presence impedes and complicates conversional surgery by obscuring crucial anatomical landmarks and hindering precise gastric sleeve or pouch formation. The aim of this study was to evaluate the incidence of a HH in patients with an LAGB undergoing conversion compared to patients undergoing primary bariatric surgery (BS). Retrospective review of consecutive BS performed between 2010 and 2015. Data collected included demographics, anthropometrics, comorbidities, previous BS, preoperative and intra-operative HH detection, operation time, perioperative complications and length of hospital stay. During the study period, 2843 patients (36% males) underwent BS. Of these, 2615 patients (92%) were "primary" (no previous BS-control group), 197 (7%) had a previous LAGB (study group), and 31 (1%) had a different previous BS and were excluded. Reasons for conversion included weight regain, band intolerance and band-related complications. Mean age and body mass index were similar between the study and the control groups. HH was preoperatively diagnosed by upper gastrointestinal (UGI) fluoroscopy in 9.1% and 9.0% of the LAGB and control groups (p = NS), respectively. However, HH was detected intra-operatively in 20.3% and 7.3%, respectively (p < 0.0001). Preoperative diagnosis of a HH by UGI fluoroscopy for patients who have undergone LAGB is unreliable. Intra-operative hiatal exploration is highly recommended in all cases of conversional BS after LAGB.

Sections du résumé

BACKGROUND
Failure or complications following laparoscopic adjustable gastric banding (LAGB) may necessitate band removal and conversional surgery. Band position and band-induced chronic vomiting create ideal conditions for de novo hiatal hernia (HH) formation. HH presence impedes and complicates conversional surgery by obscuring crucial anatomical landmarks and hindering precise gastric sleeve or pouch formation. The aim of this study was to evaluate the incidence of a HH in patients with an LAGB undergoing conversion compared to patients undergoing primary bariatric surgery (BS).
METHODS
Retrospective review of consecutive BS performed between 2010 and 2015. Data collected included demographics, anthropometrics, comorbidities, previous BS, preoperative and intra-operative HH detection, operation time, perioperative complications and length of hospital stay.
RESULTS
During the study period, 2843 patients (36% males) underwent BS. Of these, 2615 patients (92%) were "primary" (no previous BS-control group), 197 (7%) had a previous LAGB (study group), and 31 (1%) had a different previous BS and were excluded. Reasons for conversion included weight regain, band intolerance and band-related complications. Mean age and body mass index were similar between the study and the control groups. HH was preoperatively diagnosed by upper gastrointestinal (UGI) fluoroscopy in 9.1% and 9.0% of the LAGB and control groups (p = NS), respectively. However, HH was detected intra-operatively in 20.3% and 7.3%, respectively (p < 0.0001).
CONCLUSIONS
Preoperative diagnosis of a HH by UGI fluoroscopy for patients who have undergone LAGB is unreliable. Intra-operative hiatal exploration is highly recommended in all cases of conversional BS after LAGB.

Identifiants

pubmed: 30341651
doi: 10.1007/s00464-018-6509-1
pii: 10.1007/s00464-018-6509-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2231-2234

Références

Obes Surg. 2015 Oct;25(10):1822-32
pubmed: 25835983
Am J Surg. 2010 Sep;200(3):378-85
pubmed: 20409518
Surg Endosc. 2011 Aug;25(8):2626-30
pubmed: 21416182
Surg Endosc. 2016 Jan;30(1):273-8
pubmed: 25861906
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):753-7
pubmed: 24079901
Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1282-8
pubmed: 26048518
Obes Surg. 2008 Sep;18(9):1104-8
pubmed: 18431612
Obes Surg. 2010 Feb;20(2):140-7
pubmed: 19949885
Obes Surg. 2017 Sep;27(9):2279-2289
pubmed: 28405878
Surg Obes Relat Dis. 2017 Feb;13(2):e4-e8
pubmed: 27889484
Obes Surg. 2004 Nov-Dec;14(10):1327-30
pubmed: 15603646
JAMA. 2004 Oct 13;292(14):1724-37
pubmed: 15479938
Ann Surg. 2017 Mar;265(3):439-445
pubmed: 27433894
Surg Obes Relat Dis. 2017 Feb;13(2):138-142
pubmed: 27639982
Can J Surg. 2011 Feb;54(1):61-6
pubmed: 21251434
Ann Surg. 2013 Jan;257(1):87-94
pubmed: 23235396
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):48-52
pubmed: 21925963

Auteurs

Shlomi Rayman (S)

Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michael Goldenshluger (M)

Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orly Goitein (O)

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Joseph Dux (J)

Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nasser Sakran (N)

Assia Medical Group, Assuta Medical Center, Tel Aviv, Israel.
Department of Surgery A, Emek Medical Center, Afula, Israel.
Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.

Asnat Raziel (A)

Assia Medical Group, Assuta Medical Center, Tel Aviv, Israel.

David Goitein (D)

Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel. david.goitein@sheba.health.gov.il.
Assia Medical Group, Assuta Medical Center, Tel Aviv, Israel. david.goitein@sheba.health.gov.il.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. david.goitein@sheba.health.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH